Edesa Biotech, Inc. (EDSA) Social Stream
EDESA BIOTECH INC (EDSA) Price Targets From Analysts
Use the tables below to see what analysts covering EDESA BIOTECH INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 2 | $20 | $18 | $19 | $4.57 | 315.75% |
| 2022-04-28 | 2 | $20 | $16 | $18 | $4.57 | 293.87% |
| 2022-08-23 | 2 | $18 | $15 | $16.333 | $4.57 | 257.4% |
| 2022-10-03 | 2 | $16 | $15 | $15.5 | $4.57 | 239.17% |
| 2022-11-28 | 2 | $18.001 | $15 | $16.333 | $4.57 | 257.4% |
| 2022-12-20 | 2 | $16 | $13 | $14.666 | $4.57 | 220.92% |
| 2023-05-11 | 2 | $16 | $10 | $13 | $4.57 | 184.46% |
| 2023-05-24 | 2 | $16 | $6 | $11.666 | $4.57 | 155.27% |
| 2023-08-09 | 2 | $16 | $6 | $10.333 | $4.57 | 126.11% |
| 2023-08-16 | 2 | $10 | $6 | $8.333 | $4.57 | 82.34% |
| 2023-10-12 | 2 | $69.979 | $41.987 | $56.322 | $4.57 | 1132.43% |
| 2023-10-19 | 2 | $69.979 | $30 | $52.326 | $4.57 | 1044.99% |
| 2023-11-22 | 2 | $57 | $10 | $32.333 | $4.57 | 607.51% |
| 2023-11-29 | 2 | $57 | $21 | $36 | $4.57 | 687.75% |
The Trend in the Analyst Price Target
Over the past 31 months, EDSA's average price target has gone up $19.
Over the past 45 weeks, EDSA's average upside potential has been 1,372.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-18 | 2 | 16.000 | 10.000 | 13.000 | 1.470 | 784.35% |
| 2023-08-16 | 2 | 69.979 | 41.987 | 58.315 | 0.845 | 6801.18% |
| 2023-08-16 | 2 | 10.000 | 6.000 | 8.333 | 0.845 | 886.15% |
| 2023-11-22 | 2 | 57.000 | 10.000 | 32.333 | 3.162 | 922.55% |
| 2023-11-29 | 2 | 57.000 | 21.000 | 36.000 | 3.310 | 987.61% |
EDSA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 26 weeks, EDSA's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EDSA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, EDESA BIOTECH INC's number of analysts covering the stock is greater than 42.45% of them.
- EDESA BIOTECH INC's upside potential (average analyst target price relative to current price) is greater than 1449.2% of all US stocks.
- In terms of how EDESA BIOTECH INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -650.15% of that group.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, EDESA BIOTECH INC's average analyst price target is greater than 1162.43% of them.
In the Pharmaceutical Products industry, DARE, AGRX, and PHIO are the three stocks most similar to EDESA BIOTECH INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding EDSA using the data that counts. Try POWR Ratings for free.